The Food and Drug Administration (FDA) is announcing a public workshop titled, “The Role of Hospitals in Modernizing Evidence Generation for Device Evaluation: Harnessing the Digital Revolution for Surveillance” scheduled for Monday, December 5, 2016. Hospitals play a critical role in the development of these national capabilities, leading to more robust evidence generation. Recently, the role of hospital reporting of device-related adverse events in device surveillance and, more generally, device evaluation, has garnered increased scrutiny. This public workshop will further explore the critical role of hospitals in the evolution of device surveillance and in creating more robust surveillance capabilities.
This meeting will be held Monday, December 5, 2016, beginning at 8:30 a.m. to 5:00 p.m. ET, at the Fishers Lane Conference Center Terrace Level, 5635 Fishers Lane, Rockville, MD, 20852. If you wish to attend this Workshop, you must register by 4:00 p.m. on November 28, 2016. The workshop will also be webcast and the webcast link will be available on the web page.
Registration, webcast information, and additional details can be found on the workshop webpage.